Year |
Citation |
Score |
2014 |
Huang RM, Chen YN, Zeng Z, Gao CH, Su X, Peng Y. Marine nucleosides: structure, bioactivity, synthesis and biosynthesis. Marine Drugs. 12: 5817-38. PMID 25474189 DOI: 10.3390/Md12125817 |
0.312 |
|
2012 |
Su X, Halem HA, Thomas MP, Moutrille C, Culler MD, Vicker N, Potter BV. Adamantyl carboxamides and acetamides as potent human 11β-hydroxysteroid dehydrogenase type 1 inhibitors. Bioorganic & Medicinal Chemistry. 20: 6394-402. PMID 23040895 DOI: 10.1016/J.Bmc.2012.08.056 |
0.606 |
|
2012 |
Pradaux-Caggiano F, Su X, Vicker N, Thomas MP, Smithen D, Halem HA, Culler MD, Potter BVL. Synthesis and evaluation of thiadiazole derivatives as inhibitors of 11β-hydroxysteroid dehydrogenase type 1 Medchemcomm. 3: 1117-1124. DOI: 10.1039/C2Md20091K |
0.521 |
|
2011 |
Su X, Pradaux-Caggiano F, Vicker N, Thomas MP, Halem H, Culler MD, Potter BV. Adamantyl ethanone pyridyl derivatives: potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1. Chemmedchem. 6: 1616-29. PMID 21714097 DOI: 10.1002/Cmdc.201100182 |
0.594 |
|
2011 |
Su X, Vicker N, Thomas MP, Pradaux-Caggiano F, Halem H, Culler MD, Potter BV. Discovery of adamantyl heterocyclic ketones as potent 11β-hydroxysteroid dehydrogenase type 1 inhibitors. Chemmedchem. 6: 1439-51. PMID 21608132 DOI: 10.1002/Cmdc.201100144 |
0.588 |
|
2010 |
Su X, Pradaux-Caggiano F, Thomas MP, Szeto MW, Halem HA, Culler MD, Vicker N, Potter BV. Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors. Chemmedchem. 5: 1026-44. PMID 20486152 DOI: 10.1002/Cmdc.201000081 |
0.736 |
|
2009 |
Su X, Vicker N, Trusselle M, Halem H, Culler MD, Potter BV. Discovery of novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. Molecular and Cellular Endocrinology. 301: 169-73. PMID 18775471 DOI: 10.1016/J.Mce.2008.08.006 |
0.736 |
|
2008 |
Su X, Vicker N, Potter BV. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1. Progress in Medicinal Chemistry. 46: 29-130. PMID 18381124 DOI: 10.1016/S0079-6468(07)00002-1 |
0.674 |
|
2007 |
Su X, Vicker N, Lawrence H, Smith A, Purohit A, Reed MJ, Potter BV. Inhibition of human and rat 11beta-hydroxysteroid dehydrogenase type 1 by 18beta-glycyrrhetinic acid derivatives. The Journal of Steroid Biochemistry and Molecular Biology. 104: 312-20. PMID 17493801 DOI: 10.1016/J.Jsbmb.2007.03.019 |
0.704 |
|
2007 |
Vicker N, Su X, Ganeshapillai D, Smith A, Purohit A, Reed MJ, Potter BV. Novel non-steroidal inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. The Journal of Steroid Biochemistry and Molecular Biology. 104: 123-9. PMID 17482805 DOI: 10.1016/J.Jsbmb.2007.03.023 |
0.71 |
|
2006 |
Su X, Vicker N, Ganeshapillai D, Smith A, Purohit A, Reed MJ, Potter BV. Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. Molecular and Cellular Endocrinology. 248: 214-7. PMID 16325333 DOI: 10.1016/J.Mce.2005.10.022 |
0.73 |
|
2004 |
Su X, Lawrence H, Ganeshapillai D, Cruttenden A, Purohit A, Reed MJ, Vicker N, Potter BV. Novel 18beta-glycyrrhetinic acid analogues as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenases. Bioorganic & Medicinal Chemistry. 12: 4439-57. PMID 15265495 DOI: 10.1016/J.Bmc.2004.06.008 |
0.703 |
|
2004 |
Vicker N, Su X, Lawrence H, Cruttenden A, Purohit A, Reed MJ, Potter BV. A novel 18 beta-glycyrrhetinic acid analogue as a potent and selective inhibitor of 11 beta-hydroxysteroid dehydrogenase 2. Bioorganic & Medicinal Chemistry Letters. 14: 3263-7. PMID 15149687 DOI: 10.1016/J.Bmcl.2004.03.107 |
0.704 |
|
2004 |
Vicker N, Su X, Lawrence H, Cruttenden A, Purohit A, Reed MJ, Potter BVL. A Novel 18β-Glycyrrhetinic Acid Analogue as a Potent and Selective Inhibitor of 11β-Hydroxysteroid Dehydrogenase 2. Cheminform. 35. DOI: 10.1002/chin.200440183 |
0.319 |
|
Show low-probability matches. |